Lepu Medical Tech Beijing (300003.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · China · ISIN CNE100000H44

Price
12.05 CNY
Market cap
21.47 bn CNY
P/E (2025)
–
P/S (2025)
3.31
Dividend yield
2.70 %
Net margin
14.84 %
Return on equity (ROE)
5.42 %
Return on assets (ROA)
3.68 %

Lepu Medical Tech Beijing financials

Fiscal year20242025
Revenue6.10 bn CNY6.48 bn CNY
Gross profit3.55 bn CNY4.15 bn CNY
Operating income253.14 m CNY1.54 bn CNY
EBIT427.99 m CNY1.39 bn CNY
Net income246.94 m CNY962.01 m CNY

Full history since 2006, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Lepu Medical Tech Beijing

Lepu Medical Technology (Beijing) Co., Ltd., together with its subsidiaries, engages in the research, development, and manufacturing of cardiac interventional medical devices in China and internationally. The company operates through three segments: Medical Devices; Pharmaceuticals; and Medical Services and Health Management. It offers medical devices, including cardiovascular devices, in vitro diagnostics, surgical instruments, peripheral blood vessels, blood purification, ultrasound imaging, and orthopedic products; pharmaceutical products for cardiovascular, digestive, central nervous, and respiratory systems, as well as antimicrobial, nutrition, traditional Chinese medicine, lowering blood sugar, and health food; and medical services and health management, such as medical services, AI, home appliances, and medical aesthetics and daily chemical products. The company is also involved in investment activities; trading; technological development; and pension services. It exports its products. The company was founded in 1999 and is based in Beijing, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.